Sat, 02 May 2026 22:40:06 +0000

Why Third-Party Experts Refuse to Talk About Similac Sensitive—What They Won’t Admit If you’ve browsed online health forums, parenting groups, or even medical communities, you may have noticed a striking silence around Similac Sensitive—the popular infant formula designed for babies with mild sensitivities. While major brands regularly invite expert commentary, third-party specialists in pediatric nutrition, gastroenterology, and infant feeding often dodge the topic, citing undisclosed concerns. But why exactly are these experts staying quiet? And what critical information remains unspoken? Digging deeper reveals a complex landscape shaped by corporate influence, scientific ambiguity, and regulatory constraints. ### The Dominance of Similac Sensitive in Infant Nutrition Similac Sensitive has long been a staple formula for parents managing cow’s milk protein intolerance (CMPA) in infants. Marketed as a gentle, hypoallergenic option, it contains modified proteins intended to reduce allergic reactions. Its widespread acceptance by healthcare providers gives it an aura of safety and reliability. Yet, beneath this veneer of mainstream approval lies a story of controversy, subtle risks, and tight control over public discourse.